Insights & Resources San Diego Life Science

Field notes from the San Diego lab market.

Our quarterly market report, written by practitioners for the operators, founders, and advisors who hire them. Case studies and short-form analysis will follow.

Latest · Market Report

San Diego Life Science Market Report, Q3 2026

Stabilization with mixed signals: signings rise, net absorption turns negative. Stronger signed leasing and lower marketed availability support stabilization, while negative Q3 net absorption leaves a sustained recovery unconfirmed. Core Cluster market conditions, capital activity and tenant strategy.

Published October 2026 · Authors: Miles Arnold, Chris Durbin · No email gate.
Core vacancy
28.1%
Up 1.0 pt QoQ
Q3 net absorption
(215,379) SF
Q2: +121,354 SF
Signed leasing
437,771 SF
19 records; up 140.9% QoQ
Reported availability
30.5%
Down 1.1 pts QoQ
Source: Voit San Diego Life Sciences Q3 2026 Market Report.
Archive

Past reports

Every quarterly report we publish stays available here. No email gate, no expiry.

Cover of the San Diego Life Science Market Report, Q2 2026
Market Report · Published July 2026

San Diego Life Science Market Report, Q2 2026

The inflection quarter. Core cluster vacancy posted its first demand-driven decline of the cycle, Class A rents held flat after fifteen quarters of decline, and the exit environment reopened with $3.2B+ in disclosed San Diego M&A.

26.6% core cluster vacancy $624.7M Q2 VC activity, 10 rounds $3.2B+ disclosed M&A
Cover of the San Diego Life Science Market Report, Q1 2026
Market Report · Published April 2026

San Diego Life Science Market Report, Q1 2026

The quarter San Diego lab vacancy sat near cycle highs. Submarket availability and rent trends, capital markets, leasing activity, and a read on where tenant leverage was strongest heading into the second half of the year.

27.9% core cluster vacancy $5.75 /SF Class A asking rent $178M Q1 VC activity, 11 deals
Download PDF →

Next report: Q4 2026, publishing January 2027.